Protein Supplementation in Elderly With Sarcopenic Obesity Undergoing Caloric Restriction and Exercise

NCT ID: NCT04981366

Last Updated: 2025-06-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-01

Study Completion Date

2023-08-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate if protein supplementation increases the benefits of exercise training in the elderly with sarcopenic obesity undergoing caloric restriction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A major subset of adults over the age of 65 is now classified as having sarcopenic obesity, a high-risk geriatric syndrome predominantly observed in an aging population that is at risk of synergistic complications from both sarcopenia and obesity.

Lifestyle interventions such as caloric restriction and exercise training are effective nonpharmacological strategies to mitigate some adverse effects related to this condition. Also, protein supplementation may boost the benefits of exercise, but this assumption is still to be tested. This trial aims to test whether protein supplementation is able to increase the benefits of exercise training in the elderly with sarcopenic obesity undergoing caloric restriction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenic Obesity Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group (CTRL)

Patients allocated to this arm will not receive any intervention.

Group Type NO_INTERVENTION

No interventions assigned to this group

Caloric Restriction associated to exercise training plus protein supplementation (CREX+PTN)

Patients allocated to this arm will be submitted to caloric restriction associated with exercise training program plus protein supplementation.

Group Type EXPERIMENTAL

Protein supplement

Intervention Type DIETARY_SUPPLEMENT

40g of whey protein in the breakfast;

Caloric Restriction associated to exercise training plus isocaloric placebo (CREX+PLA)

Patients allocated to this arm will be submitted to caloric restriction associated with exercise training program plus isocaloric placebo.

Group Type PLACEBO_COMPARATOR

isocaloric supplement

Intervention Type DIETARY_SUPPLEMENT

42g of isocaloric supplement in the breakfast;

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Protein supplement

40g of whey protein in the breakfast;

Intervention Type DIETARY_SUPPLEMENT

isocaloric supplement

42g of isocaloric supplement in the breakfast;

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 65 years and older;
* Body mass index (BMI) \> 30 kg/m2;
* Sarcopenia;
* not engage into exercise training programas.

Exclusion Criteria

* cancer in the last 5 years;
* cognitive deficit or dementia that impossibility the patient to read and sign the informed consent form;
* any disease that limits participation in exercise training program.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sao Paulo General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hamilton Augusto Roschel da Silva

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hamilton Roschel, Phd

Role: PRINCIPAL_INVESTIGATOR

University of Sao Paulo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Sao Paulo

São Paulo, , Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

04234918.1.0000.0065

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.